Literature DB >> 2575393

Biodegradability of synthetic branched polypeptide with poly(L-lysine) backbone.

F Hudecz1, S Kutassi-Kovács, G Mezö, M Szekerke.   

Abstract

A detailed investigation is reported about the biodegradation of poly[Lys(DL-Alam)], m approximately 3, (AK) the common inside area of a branched polypeptide model system developed by our group over the last decade. Enzymatic hydrolysis was carried out by the exopeptidase aminopeptidase M, or the endopeptidase trypsin, or their mixture. Ion-exchange column chromatography, paper electrophoresis and thin-layer chromatography were utilised to achieve separation of metabolites. Breakdown products were identified by the aid of synthetic oligopeptides representing the potential fragments (DL-Ala2, DL-Ala3, Lys(DL-Alam), m = 1-3). The kinetics and the degree of enzymatic degradation were determined. The ratio of peptide/amino acid amounts in the hydrolysate was found to be 1.07 after 24 h treatment with aminopeptidase M, 3.0 with trypsin and 1.3 with aminopeptidase - trypsin mixture. The overall results indicated that the proteolysis of AK by an aminopeptidase M and trypsin mixture proceeds stepwise at multiple sites on the polypeptide chain. The degradation is significantly retarded as compared to that of alpha- or epsilon-polylysine. A mechanism of degradation is suggested based on the experimental results.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575393     DOI: 10.1515/bchm3.1989.370.2.1019

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  3 in total

1.  Antitumour effect of a gonadotropin-releasing-hormone antagonist (MI-1544) and its conjugate on human breast cancer cells and their xenografts.

Authors:  B Vincze; I Pályi; D Daubner; A Kálnay; G Mezö; F Hudecz; M Szekerke; I Teplán; I Mezö
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

2.  Biodistribution in tumour-bearing mice of polycationic, amphoteric and polyanionic branched polypeptides with a poly(L-lysine) backbone labelled with 125I and 111In: tumour accumulation less than that of labelled serum proteins.

Authors:  M V Pimm; F Hudecz
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity.

Authors:  Peihao Yin; Yan Wang; YanYan Qiu; LiLi Hou; Xuan Liu; Jianmin Qin; Yourong Duan; Peifeng Liu; Ming Qiu; Qi Li
Journal:  Int J Nanomedicine       Date:  2012-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.